|
Pfizer EVP & CCO Rady Johnson, JD Joins Keynote Faculty of the Virtual 22nd Pharmaceutical & Medical Device Ethics and Compliance Congress
|
- Virtual Online Video Event Live and 6 Months Access to Video Archive
- Sponsored by the Pharmaceutical Compliance Forum (PCF)
- Featuring Invitation-only CCO Roundtable & Industry-only Best Practice Exchange Day
- Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
- Broadcast on November 2 - 5, 2021 and Video Archived Thereafter
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com |
KEYNOTE ADDRESS
|

Rady Johnson, JD
Executive Vice President and Chief Compliance, Quality & Risk Officer, Pfizer Inc. |
Interviewed by

Indrani Franchini, JD
Former Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE -- AUGUST 24, 2021: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce the Virtual Twenty Second Pharmaceutical & Medical Device Ethics and Compliance Congress which will be broadcast on November 2 - 5, 2021 and video archived thereafter, will feature a keynote Fireside Chat with Rady Johnson, JD, Executive Vice President and Chief Compliance, Quality & Risk Officer, Pfizer Inc. interviewed by PCF executive committee member Indrani Franchini.
|
KEYNOTE SPEAKERS
|

Giovanni Caforio, MD
Chairman and Chief Executive Officer, Bristol Myers Squibb, Princeton, NJ |

Catherine (Katie) Gray, PharmD
Acting Director, FDA Office of Prescription Drug Promotion |

Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services |

Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice
|
INVITATION-ONLY CCO ROUNDTABLE
|
Sponsored by PCF, AdvaMed & PhRMA
Tuesday 11/2
PhRMA Update

Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA |
AdvaMed Update

Nancy Schwalje Travis, MA
VP, Global Compliance & Governance, AdvaMed
|
|
INDUSTRY-ONLY DAY
|
Closed Session for Industry Ethics & Compliance
Professionals & In-house Counsel For Dialogue on Best Practices
Friday 11/5
Featuring

Craig Carpenito, JD
Partner, King & Spalding; Former United States Attorney, District of New Jersey
|
|
THE ANNUAL CCO FIRESIDE CHAT WITH
|

Ann E. Beasley, JD
Chief Compliance Officer, Zai Lab |

Shefali Kothari, JD
VP, CCO (US), Novartis |

Angela Main, JD
SVP, Global CCO & Associate GC, Asia Pacific, Zimmer Biomet
|

Kristin Rand, JD, MA
Head, Corporate Compliance and Global Risk Officer, Moderna |

Latarsha Stewart, JD, MS
VP, Head of Compliance, Servier Pharmaceuticals |

Tom Gregory, MBA
Global & US Leader, Health & Life Sciences, Forensic & Integrity Services, EY (Moderator)
|
|
AUSA ROUNDTABLE
|

Matthew J. Lash, JD
Trial Attorney, Consumer Protection Branch, Civil Division, US Department of Justice |

Abraham George, JD
Assistant US Attorney, US Attorney’s Office, District of Massachusetts, US Department of Justice |

Nicholas Grippo, JD
Assistant US Attorney and Attorney in Charge, Trenton Office, US Attorney’s Office, District of New Jersey, US Department of Justice
|
|

John T. Bentivoglio, JD
Partner, Skadden Arps LLP (Moderator) |
|
PCF EXECUTIVE COMMITTEE
|

Joe Zimmerman
Vice President, Chief Compliance Officer & Privacy Officer, Ferring Pharmaceuticals, Inc., Parsippany, NJ (PCF Chair) |
"We consulted with our membership and the majority recommended that we hold the Congress again in 2021 as a purely virtual event. Some of our member companies have still not allowed in-person attendance at conferences. Barring unexpected developments, we are currently planning to return to the hybrid model in 2022 which will offer registrants the option of participation onsite or online."
- PCF Executive Committee
|

Indrani Franchini, JD
Executive Vice President Chief Compliance Officer, Alexion Pharmaceuticals, New York, NY (PCF Co-Chair) |

Joshua Marks, JD
Vice President, Chief Ethics & Compliance Officer, Boehringer Ingelheim, Ridgefield, CT (PCF Co-Chair) |

Margaret Sparks, JD
Head of Compliance, Vaccines, North America Ethics and Business Integrity, Sanofi, Bridgewater, NJ (PCF Co-Chair)
|

Ann-Marie Tejcek, MA
Senior Director, Chief Compliance Officer North America, Eli Lilly, Indianapolis, IN (PCF Co-Chair) |

Donna White, CCEP
Vice President, Compliance, Chiesi, USA, Cary, NC (PCF Co-Chair)
|
|
MEDICAL DEVICE STEERING COMMITTEE
|

Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc. |

Ethan Gumpert
Global Ethics, Compliance & Governance, Advanced Medical Technology Association (AdvaMed) |

Daniel Spicehandler, JD
Vice President Compliance- Commercial Divisions, Stryker
|
|
FEATURING THE PHARMA & MEDICAL DEVICE CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL
|
Featuring one-on-one attendee video chat and large group video interactive workshops.
See last year's Congress portal:

|
|
|
|
|
REGISTER BY 9/10 FOR EARLY BIRD RATES
|
- Click here to register.
|
FEATURING
|
- An invitation-only CCO Roundtable
- A Day 4 Industry-only Interactive Best Practice Closed Session
- Attendee One-on-One Video Conferencing and Group Texting
- Live Video Interactive Workshops
|
NEW REGISTRATION RATES FOR A VIRTUAL AGE
|
Early bird registration discounts now available with special PCF member rates. Rates are up to $1,000 less than major competing events.
- Click Here -
|
SPONSORED BY
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 85+ distinguished researched-based pharmaceutical manufacturers and biotech companies. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effect corporate compliance programs.
|
GRANTORS
|
GOLD
|

|
SILVER
|

|
BRONZE
|














|
MEDIA PARTNERS
|



|
|
CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
|
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|